Literature DB >> 8242886

Troponin-T and CK MB (mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study, 1992.

W Gerhardt, L Ljungdahl, A K Herbert.   

Abstract

We evaluated cardiac troponin T (S-troponin T) versus CK MB in serum (S-CK MB) sampled 4, 10, 16, and 22 h after onset of acute symptoms in 207 consecutive cases admitted to our coronary care unit in Helsingborg, Sweden, May-October 1992. These were primarily classified into 106 acute myocardial infarctions (AMI) and 101 NOT-AMI cases by conventional cardiological criteria plus S-CK MB (mass). Time curves of S-troponin T and S-CK MB data were plotted for each individual case. Twelve of the 101 cases in the NOT-AMI group showed increased S-troponin T indicating ischemic myocardial injuries. The same cases also showed changes of S-CK MB (mass), though below its discriminator. Seven of these cases were reclassified as minor myocardial damage, constituting 25% of our 28 cases of unstable angina. The remaining five cases showed a combination of constantly increased S-troponin T and decreasing or low S-CK MB mass values as seen after a recent infarction. Consequently, the patient material was reclassified into 118 cases of ischemic myocardial injury (106 conventional AMI + 7 minor myocardial damage + 5 postinfarctions) and 89 cases of NOT-ischemic myocardial injury. The frequency distributions of the maximal S-troponin T and S-CK MB (mass) values of each case were plotted in double test evaluation histograms. For troponin T, discriminator 0.20 micrograms/L, clinical sensitivity for ischemic myocardial injury was 97% and specificity 99%. With a lower discriminator of 0.10 micrograms/L, sensitivity increased to 99% and specificity decreased to 89%. For S-CK MB (mass), discriminator 10 micrograms/L, sensitivity was 91%, specificity 98%. With a lower discriminator of 5 micrograms/L sensitivity increased to 96% and specificity decreased to 78%. We conclude that as a single routine test, S-troponin T is the marker of choice for early diagnosis of ischemic myocardial damage. The combination S-troponin T and S-CK MB (mass) provides additional, detailed information in reinfarction and postinfarction unstable angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242886     DOI: 10.1016/0009-9120(93)90122-m

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

Review 1.  Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury.

Authors:  K H Haider; W H Stimson
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

2.  Diagnostic role of postmortem CK-MB in cardiac death: a systematic review and meta-analysis.

Authors:  Chengyang Xu; Tianyi Zhang; Baoli Zhu; Zhipeng Cao
Journal:  Forensic Sci Med Pathol       Date:  2020-03-19       Impact factor: 2.007

3.  Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome.

Authors:  Hafidh A Al-Hadi; Keith A Fox
Journal:  Sultan Qaboos Univ Med J       Date:  2009-12-19

4.  Diagnosis of myocardial infarction: integration of serum markers and clinical descriptors using information theory.

Authors:  L H Bernstein; A Qamar; C McPherson; S Zarich; R Rudolph
Journal:  Yale J Biol Med       Date:  1999 Jan-Feb

5.  Evaluating a new graphical ordinal logit method (GOLDminer) in the diagnosis of myocardial infarction utilizing clinical features and laboratory data.

Authors:  L H Bernstein; A Qamar; C McPherson; S Zarich
Journal:  Yale J Biol Med       Date:  1999 Jul-Aug

6.  Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties.

Authors:  Adithan Aravinthan; Jong Han Kim; Paulrayer Antonisamy; Chang-Won Kang; Jonghee Choi; Nam Soo Kim; Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2014-12-23       Impact factor: 6.060

7.  Korean Red Ginseng Induced Cardioprotection against Myocardial Ischemia in Guinea Pig.

Authors:  Kyu Hee Lim; Chang-Won Kang; Jin-Yong Choi; Jong-Hoon Kim
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.